Sep 18, 2017 12:00 pm UTC| Business
CHRISTIANSTED, St. Croix, Sept. 18, 2017 -- The Rosen Law Firm, P.A. announces that the United States District Court for the District of the Virgin Islands has approved the following announcement of a proposed class...
IntelliChief ECM’s Integration Link Named KMWorld’s Trend-Setting Product
Sep 18, 2017 12:00 pm UTC| Business
Tampa, FL, Sept. 18, 2017 -- IntelliChief LLC, a provider of automated document management and workflow enterprise content management (ECM) solutions, announces IntelliChief ECM’s Integration Link named KMWorld’s...
T2 Biosystems to Present at the Cantor Fitzgerald Global Healthcare Conference
Sep 18, 2017 12:00 pm UTC| Business
LEXINGTON, Mass., Sept. 18, 2017 -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today announced that John McDonough, president...
ADP Selects CallidusCloud for Litmos Learning
Sep 18, 2017 12:00 pm UTC| Business
DUBLIN, Calif., Sept. 18, 2017 -- Callidus Software Inc. (NASDAQ:CALD), a global leader in cloud-based sales, marketing, learning and customer experience solutions, announced today that ADP selected Litmos Mobile...
Emergent BioSolutions Awarded $63 Million BARDA Contract to Develop Treatment for Cyanide Exposure
Sep 18, 2017 12:00 pm UTC| Business
GAITHERSBURG, Md., Sept. 18, 2017 -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has been awarded a contract valued at approximately $63 million by the Biomedical Advanced Research and Development...
iBio and TheoremDx Collaborate to Develop Proteins for Rapid Diagnostics Testing Products
Sep 18, 2017 12:00 pm UTC| Business
NEW YORK, Sept. 18, 2017 -- iBio, Inc. (NYSE AMERICAN:IBIO) – iBio, with its subsidiary, iBio CDMO LLC in Bryan/College Station, Texas ("iBio CDMO"), has partnered with TheoremDx, Inc., in Edina, Minnesota, to develop...
Athenex, Inc. Added to Russell 2000® and Russell 3000® Indexes
Sep 18, 2017 12:00 pm UTC| Business
BUFFALO, N.Y., Sept. 18, 2017 -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer, today...